Cencora Total Long Term Liabilities 2010-2025 | COR
Cencora total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Cencora total long term liabilities for the quarter ending March 31, 2025 were $16.686B, a 29.56% increase year-over-year.
- Cencora total long term liabilities for 2024 were $12.038B, a 7.84% decline from 2023.
- Cencora total long term liabilities for 2023 were $13.061B, a 0.38% increase from 2022.
- Cencora total long term liabilities for 2022 were $13.011B, a 15.48% decline from 2021.
| Cencora Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $12,038 |
| 2023 | $13,061 |
| 2022 | $13,011 |
| 2021 | $15,395 |
| 2020 | $11,261 |
| 2019 | $6,597 |
| 2018 | $6,750 |
| 2017 | $6,434 |
| 2016 | $6,228 |
| 2015 | $5,768 |
| 2014 | $2,325 |
| 2013 | $1,728 |
| 2012 | $1,722 |
| 2011 | $1,241 |
| 2010 | $1,574 |
| 2009 | $1,377 |
| Cencora Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $16,686 |
| 2024-12-31 | $14,183 |
| 2024-09-30 | $12,038 |
| 2024-06-30 | $12,738 |
| 2024-03-31 | $12,879 |
| 2023-12-31 | $12,856 |
| 2023-09-30 | $13,061 |
| 2023-06-30 | $13,472 |
| 2023-03-31 | $13,184 |
| 2022-12-31 | $13,073 |
| 2022-09-30 | $13,011 |
| 2022-06-30 | $13,501 |
| 2022-03-31 | $13,605 |
| 2021-12-31 | $15,363 |
| 2021-09-30 | $15,395 |
| 2021-06-30 | $15,933 |
| 2021-03-31 | $14,110 |
| 2020-12-31 | $11,314 |
| 2020-09-30 | $11,261 |
| 2020-06-30 | $6,190 |
| 2020-03-31 | $6,225 |
| 2019-12-31 | $6,317 |
| 2019-09-30 | $6,597 |
| 2019-06-30 | $6,582 |
| 2019-03-31 | $6,560 |
| 2018-12-31 | $6,751 |
| 2018-09-30 | $6,750 |
| 2018-06-30 | $6,934 |
| 2018-03-31 | $6,938 |
| 2017-12-31 | $6,747 |
| 2017-09-30 | $6,434 |
| 2017-06-30 | $6,349 |
| 2017-03-31 | $6,336 |
| 2016-12-31 | $6,260 |
| 2016-09-30 | $6,228 |
| 2016-06-30 | $6,038 |
| 2016-03-31 | $6,533 |
| 2015-12-31 | $5,431 |
| 2015-09-30 | $5,768 |
| 2015-06-30 | $4,641 |
| 2015-03-31 | $4,863 |
| 2014-12-31 | $2,332 |
| 2014-09-30 | $2,325 |
| 2014-06-30 | $2,305 |
| 2014-03-31 | $1,716 |
| 2013-12-31 | $1,719 |
| 2013-09-30 | $1,728 |
| 2013-06-30 | $1,719 |
| 2013-03-31 | $1,723 |
| 2012-12-31 | $1,723 |
| 2012-09-30 | $1,722 |
| 2012-06-30 | $1,867 |
| 2012-03-31 | $1,784 |
| 2011-12-31 | $1,772 |
| 2011-09-30 | $1,241 |
| 2011-06-30 | $1,645 |
| 2011-03-31 | $1,598 |
| 2010-12-31 | $1,529 |
| 2010-09-30 | $1,574 |
| 2010-06-30 | $1,586 |
| 2010-03-31 | $1,564 |
| 2009-12-31 | $1,572 |
| 2009-09-30 | $1,377 |
| 2009-06-30 | $1,364 |
| 2009-03-31 | $1,313 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $56.610B | $293.959B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.426B | 25.40 |
| Elevance Health (ELV) | United States | $85.189B | 10.99 |
| CVS Health (CVS) | United States | $80.455B | 10.00 |
| DiDi Global (DIDIY) | China | $22.073B | 33.50 |
| Natera (NTRA) | United States | $21.942B | 0.00 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.094B | 0.00 |
| Solventum (SOLV) | United States | $12.651B | 13.39 |
| CochLear (CHEOY) | Australia | $11.541B | 0.00 |
| Revvity (RVTY) | United States | $10.528B | 18.12 |
| ICON (ICLR) | Ireland | $10.410B | 9.68 |
| Viatris (VTRS) | United States | $10.199B | 3.50 |
| Doximity (DOCS) | United States | $9.673B | 44.78 |
| HealthEquity (HQY) | United States | $8.893B | 43.75 |
| Avantor (AVTR) | United States | $8.831B | 12.83 |
| Medpace Holdings (MEDP) | United States | $8.560B | 22.73 |
| Sonic Healthcare (SKHHY) | Australia | $8.409B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.633B | 13.00 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.170B | 38.60 |
| Bausch + Lomb (BLCO) | Canada | $4.047B | 23.85 |
| Sotera Health (SHC) | United States | $3.460B | 19.66 |
| Alignment Healthcare (ALHC) | United States | $3.069B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.998B | 38.98 |
| Concentras Parent (CON) | United States | $2.754B | 15.92 |
| Organon (OGN) | United States | $2.405B | 2.56 |
| GeneDx Holdings (WGS) | United States | $2.115B | 81.46 |
| Ardent Health Partners (ARDT) | United States | $2.061B | 8.79 |
| Premier (PINC) | United States | $1.882B | 14.29 |
| Progyny (PGNY) | United States | $1.860B | 40.94 |
| PACS (PACS) | United States | $1.495B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.364B | 27.29 |
| Teladoc Health (TDOC) | United States | $1.205B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.163B | 8.85 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.982B | 0.00 | |
| CareDx (CDNA) | United States | $0.951B | 14.85 |
| Nutex Health (NUTX) | United States | $0.935B | 14.13 |
| Agilon Health (AGL) | United States | $0.931B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.777B | 7.28 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.611B | 4.11 |
| LifeMD (LFMD) | United States | $0.584B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.528B | 0.00 |
| Enhabit (EHAB) | United States | $0.525B | 43.21 |
| SBC Medicals (SBC) | United States | $0.484B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.482B | 10.85 |
| Sonida Senior Living (SNDA) | United States | $0.457B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.290B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.247B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.152B | 24.83 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.128B | 0.00 |
| So-Young (SY) | China | $0.092B | 0.00 |
| OncoCyte (OCX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.041B | 0.00 |
| ModivCare (MODV) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |